Establishment Labs Holdings Inc. (ESTA) — 分析摘要
Establishment Labs Holdings Inc.（ESTA）的市值为2.59十亿美元，最近一年的营收同比增长了+27.1%。净利润率为-24.2%。当前市盈率为-59.1倍。
核心要点
- 营收同比变化+27.1%
- 净利润率-24.2%
- 市盈率-59.1倍
与ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES板块的其他公司相比，ESTA的营收增长为+27.1%，市盈率为-59.1倍。
Establishment Labs Holdings Inc. (ESTA)
更新 — ET · 来源 POLYGON
红旗与风险提示高风险信号
存在多项实质性红旗，在依赖任何估值输出前应先重点核查这些风险。
利息保障倍数为 -1.1x — 盈利不足以覆盖利息支出
D/E 为 16.8x — 杠杆极高
营业利润率为 -12.4% — 经营亏损显著
最新报表显示自由现金流为负。
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
行业
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
员工人数
1,004
总部
ALAJUELA, G2
Exchange
XNAS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析，不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
免责声明：本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。